SCHEMBL457778

SCHEMBL457778

Clc1ccc(-c2ccccc2)cc1Br

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 2/20 0.52
CRHBP P24387 1/20 0.50
CRHR2 Q13324 1/20 0.50
ALDH1A1 P00352 4/20 0.48
MAPK1 P28482 2/20 0.48
CYP1A2 P05177 1/20 0.48
AHR P35869 2/20 0.44
ERCC5 P28715 1/20 0.42
FEN1 P39748 1/20 0.42
ALOX5 P09917 1/20 0.41
AKR1C4 P17516 1/20 0.40
AKR1C3 P42330 1/20 0.40
AKR1C2 P52895 1/20 0.40
AKR1C1 Q04828 1/20 0.40
CYP2A6 P11509 1/20 0.39
HDAC8 Q9BY41 2/20 0.39
HDAC6 Q9UBN7 2/20 0.39
MAOB P27338 1/20 0.39
HDAC1 Q13547 1/20 0.39
MAOA P21397 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29921215 1.00 ESR2 (0.52) ESR2CRHBPCRHR2ALDH1A1MAPK1
SCHEMBL30582700 0.85 ALDH1A1 (0.50) ESR2CRHBPCRHR2ALDH1A1MAPK1
SCHEMBL26805871 0.84 AHR (0.46) ESR2ALDH1A1MAPK1AHRCYP2A6
SCHEMBL30969417 0.82 MEN1 (0.46) CRHBPCRHR2ALDH1A1MAPK1CYP1A2
SCHEMBL23182448 0.82 ESR2 (0.57) ESR2CRHBPCRHR2ALDH1A1MAPK1
SCHEMBL457004 0.82 ESR2 (0.57) ESR2CRHBPCRHR2ALDH1A1MAPK1
SCHEMBL30510018 0.80 AHR (0.42) AHRCYP1B1KDM4EHSD17B10
SCHEMBL25296559 0.80 AHR (0.42) AHRCYP1B1KDM4EHSD17B10
SCHEMBL30834751 0.79 AHR (0.38) ESR2CRHBPCRHR2AHRALOX5
SCHEMBL25463591 0.78 MAPT (0.46) AHRLMNAMAPTHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4618755-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN Larkspur Biosciences, Inc. (US) 2025-09-24 EP disclosed
WO-2025110612-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2025-05-30 WO disclosed
US-20250026730-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME LT MATERIALS CO., LTD. (KR) 2025-01-23 US disclosed
WO-2024107746-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES (US) 2024-05-23 WO disclosed
WO-2024107746-A1 INHIBITORS AND DEGRADERS OF PIP4K PROTEIN LARKSPUR BIOSCIENCES (US) 2024-05-23 WO disclosed
CN-117843622-A Compound for organic optoelectronic device, composition for organic optoelectronic device, and display device 三星SDI株式会社 2024-04-09 CN disclosed
CN-116670253-A Organic light emitting device 株式会社LG化学 2023-08-29 CN disclosed
WO-2023153169-A1 ORGANIC COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT キヤノン株式会社 2023-08-17 WO disclosed
CN-116406530-A Organic light emitting device 株式会社LG化学 2023-07-07 CN disclosed
CN-115745932-A Compound for organic photoelectric device, organic photoelectric device and display device 三星SDI株式会社 2023-03-07 CN disclosed
CN-110183333-A A kind of electroluminescent organic material and the organic electroluminescence device comprising the material 陕西莱特光电材料股份有限公司 2019-08-30 CN disclosed
US-8829502-B2 Condensed polycyclic compound and organic light emitting element including the same CANON KABUSHIKI KAISHA (JP) 2014-09-09 US disclosed
US-8829502-B2 Condensed polycyclic compound and organic light emitting element including the same CANON KABUSHIKI KAISHA (JP) 2014-09-09 US disclosed
US-8829502-B2 Condensed polycyclic compound and organic light emitting element including the same CANON KABUSHIKI KAISHA (JP) 2014-09-09 US disclosed
EP-2614053-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY LIMITED (JP) 2013-07-17 EP disclosed
CN-102951991-A Condensed polycyclic compound and organic light emitting element including the same CANON KK 2013-03-06 CN disclosed
US-20130048965-A1 CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-28 US disclosed
US-20130048965-A1 CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-28 US disclosed
US-20130048965-A1 CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CANON KABUSHIKI KAISHA (JP) 2013-02-28 US disclosed
WO-2012033225-A1 METHOD FOR PRODUCING PYRIDAZINONE COMPOUNDS AND INTERMEDIATE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130048965-A1 CONDENSED POLYCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT INCLUDING THE SAME CCNE2, NFE2L2, CRY2 ESR2 181/4885CRHBP 2369/4885CRHR2 1626/4885
US-20250026730-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME CRY1, CYP1A1, CYP1B1 ESR2 595/4885CRHBP 4133/4885CRHR2 3147/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.